Do you want to volunteer for Clinical Trials? Register now

Volunteer for Clinical Trials

Have you ever thought about taking part in a Medical Trial? By registering your details with, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.

Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.

Register now >

Clinical Trials and Medical Trials is a website that will put you in direct contact with Pharmaceutical Companies, CRO’s (Clinical Research Organisations) and Clinical Investigators that are running Phase I (1) and Phase II (2) clinical trials.

Medical trials are an integral part of the drug development process. Patient and volunteer participation is vital for continued medical research and these trials are carried out under strict regulations.

Register as a Clinical Trial volunteer.

View information about current Clinical Trials.

If at any point you feel that you have changed your mind and are no longer interested in undertaking a medical trial you can unsubscribe from our service. If you are already part way through a medical trial, speak to the Clinical Investigator and they will advise you of your options.

Clinical research companies often offer financial compensation for your time and expenses.

Clinical Trial Information

Register now for clinical trials


Investigational biologic cleared skin better, faster and for longer than ustekinumab in Phase II psoriasis study

New results from a Phase II head-to-head psoriasis study showed superior efficacy of Boehringer Ingelheim’s investigational biologic compound BI 655066*, over ustekinumab. Go to Source

more >

Long-term efficacy of Gilenya reinforced by new ‘no evidence of disease activity’ (NEDA-4) analysis in MS patients over seven years

Novartis has announced a new analysis from the phase III FREEDOMS and FREEDOMS II trials reinforcing the long-term efficacy profile of Gilenya® (fingolimod). Go to Source

more >

New data presented from large studies consolidating the effectiveness, safety and tolerability of Sativex in patients with spasticity symptoms in MS

Almirall, the global pharmaceutical company based in Barcelona, presented new clinical evidences of Sativex®, the only medicine derived from cannabinoids to treat spasticity symptoms in MS… Go to Source

more >

Bavarian Nordic announces initiation of safety and immunogenicity study of Ebola vaccine regimen in Sierra Leone

Bavarian Nordic A/S has announced the initiation of a new clinical study of the Ebola prime-boost vaccine regimen that combines Bavarian Nordic’s MVA-BN® Filo vaccine with the Ad26. Go to Source

more > launches Metastatic Trial Search (BCT) has teamed up with five breast cancer advocacy organizations to make finding out about clinical trial options for metastatic breast cancer easier, faster, and more… Go to Source

more >

New data show strong, sustained effects of TECFIDERA (dimethyl fumarate) in newly-diagnosed and early disease course multiple sclerosis patients

Biogen presented new data that reinforce the proven efficacy and well-established safety profile of TECFIDERA® (dimethyl fumarate) in a broad range of people with relapsing-remitting multiple… Go to Source

more >